The FY26 Breast Cancer Research Program supports highly integrated, multidisciplinary consortia of scientists, clinicians, and consumer advocates to address major breast cancer challenges. The award funds collaborative efforts that can achieve transformative impact beyond what individual investigators could accomplish, requiring inclusion of multiple PIs and consumer advocates.
Open to any type of entity with no explicit restrictions. Requires inclusion of breast cancer consumer advocates and multiple principal investigators in consortium applications.
